The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Commentary & Opinion

India's Contribution to Global Health R&D Needs Domestic, International Support

August 29, 2012

As the BRIC countries -- Brazil, Russia, India, and China -- invest more in innovations in health technologies and other areas, "many are looking to these countries to correct the global health research and development (R&D) imbalance that leaves the poor without needed products such as an improved tuberculosis (TB) vaccine or tests to help diagnose patients in remote rural settings," David de Ferranti, president of Results for Development Institute (R4D), writes in the Huffington Post Blog. Writing that "India, which has already played such an important role in manufacturing affordable antiretroviral drugs, vaccines, and other essential health commodities for developing countries," de Ferranti asks whether India "is ... ready to play a leading role in health R&D?"

De Ferranti notes that a yearlong study by R4D "concludes that India has much to contribute to global health R&D, but Indian innovators cannot meet this challenge alone, and important obstacles still have to be addressed." He continues, "Furthermore, India's potential over the next few years is different across different classes of products, with the country better poised to contribute in vaccines and diagnostic tests than in traditional drug development." De Ferranti outlines how the Indian vaccine, drug, and diagnostics industries are approaching new product development, and he writes that new R&D programs "must be driven by the Indian government, but donor agencies and international partners should continue to lend a hand by creating funding programs that complement government initiatives and focus on diseases of the poor, promoting technology transfer and clarifying the patent landscape for needed products, and articulating their top international procurement priorities" (8/28).

Back to other news for August 2012

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
See Also
More on HIV/AIDS Treatment in India

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:



Warning: file_put_contents() [function.file-put-contents]: Only 0 of 12 bytes written, possibly out of free disk space in /var/www/thebody/deploy/releases/20150831141225/bodycmslib/lib/ on line 1473